IntroductionInsulin-mediated vasodilation has been proposed as a determinant of in vivo insulin sensitivity. We tested whether sustained vasodilation with adenosine could overcome the muscle insulin resistance present in mildly overweight patients with essential hypertension. Using the forearm technique, we measured the response to a 40-min local intraarterial infusion of adenosine given under fasting conditions (n = 6) or superimposed on a euglycemic insulin clamp (n = 8). In the fasting state, adenosine-induced vasodilation (forearm blood flow from 2.6+0.6 to 6.0±+1.2 ml min-'dl-', P < 0.001) was associated with a 45% rise in muscle oxygen consumption (5.9+1.0 vs 8.6+1.7 amol min'-dl-', P < 0.05), and a doubling of forearm glucose uptake (0.47+0.15 to 1.01+0.28 ,Amol min'-dl'-, P < 0.05). The latter effect remained significant also when expressed as a ratio to concomitant oxygen balance (0.08±0.03 vs 0.13+0.04 jAmol tumol'-, P < 0.05), whereas for all other metabolites (lactate, pyruvate, FFA, glycerol, citrate, and 13-hydroxybutyrate) this ratio remained unchanged.During euglycemic hyperinsulinemia, whole-body glucose disposal was stimulated (to 19+3 jmol min-'kg-'), but forearm blood flow did not increase significantly above baseline (2.9+0.2 vs 3.1+0.2 ml min'-dl'`, P = NS). Forearm oxygen balance increased (by 30%, P < 0.05) and forearm glucose uptake rose fourfold (from 0.5 to 2.3 Amol min-'dl-', P < 0.05). Superimposing an adenosine infusion into one forearm resulted in a 100% increase in blood flow (from 2.9+0.2 to 6.1+0.9 ml min-'dl-', P < 0.001); there was, however, no further stimulation of oxygen or glucose uptake compared with the control forearm. During the clamp, the ratio of glucose to oxygen uptake was similar in the control and in the infused forearms (0.27±0.11 and 0.23+0.09, respectively), and was not altered by adenosine (0.31±0.9 and 0.29+0.10). We conclude that in insulin-rel5-76sistant patients with hypertension, adenosine-induced vasodilation recruits oxidative muscle tissues and exerts a modest, direct metabolic effect to promote muscle glucose uptake in the fasting state. Despite these effects, however, adenosine does not overcome muscle insulin resistance. (J. Clin. Invest. 1994. 94:1570-1576 (3)(4)(5). The role of blood flow, and, consequently, of the supply of glucose and insulin to target tissues in the physiologic modulation of in vivo glucose metabolism has been recently reevaluated. Evidence has been provided that systemic insulin infusion with maintenance of euglycemia is associated with peripheral vasodilation (6). When regional data have been extrapolated to the whole body, the insulin-induced increase in blood flow has been estimated to explain up to 50% of the total amount of glucose taken by skeletal muscle (7). Furthermore, typical states of insulin resistance, such as obesity and diabetes mellitus, have been reported to manifest both cellular (i.e., reduced arterio-venous gradient) and vascular (i.e., blunted vasodilation) resistance to insulin action (7,8). Thus, the ...